The NASH Summit Europe for 2017 will be led by Peter G. Traber, M.D., chief medical officer and chief executive officer of Galectin Therapeutics, Inc, located in Norcross.
As Chair of the Conference, Dr. Traber played a major role in organizing it and will provide the opening and closing remarks.
Dr. Traber commented that being appointed as the as Chair of the Conference for this year is a way to recognize all the hard work his company has done to help those afflicted with this disease. especially as there is currently no cure for nonalcoholic steatohepatitis (NASH), which has a patient population in the millions.
This conference sees the top scientists and clinicians who are working on the disease come together to discuss developments in diagnosing patients, ways to improve the efficacy of drugs, and identify innovations in clinical practice.
The Summit is focused exclusively on NASH and attended by leading experts in the industry. Its speakers and sessions cover the latest insights in solving the challenges ranging from drug discovery to late stage clinical development.
The Summit will take place from October 10 to 12 at The Westin Grand Frankfurt in Frankfurt, Germany.
Companies like Galectin Therapeutics use mailers or Flyers to inform those in the industry of major announcements such as their representatives appearing at international conferences.
Get a Free Quote for Flyers
Location
3940 Buford Hwy
STE A106
Duluth, GA 30096
Get Directions →
Phone
Hours
Mon: 9:00 - 5:00
Tue: 9:00 - 5:00
Wed: 9:00 - 5:00
Thu: 9:00 - 5:00
Fri: 9:00 - 5:00
Sat: Closed
Sun: Closed